What is Cronos Group?
Founded in 2012 and headquartered in Toronto, Ontario, Cronos Group is a global cannabinoid company with an international footprint spanning production and distribution across five continents. The company operates within the burgeoning cannabis industry, focusing on the development and commercialization of cannabinoid-based products. Its global reach and established infrastructure position it as a key player in a rapidly evolving market.
How much funding has Cronos Group raised?
Cronos Group has raised a total of $5.8M across 2 funding rounds:
Private Equity
$1.1M
Private Equity
$4.6M
Private Equity (2015): $1.1M, investors not publicly disclosed
Private Equity (2016): $4.6M, investors not publicly disclosed
What's next for Cronos Group?
The recent major strategic investment signals a new phase of growth for Cronos Group, likely aimed at scaling operations, expanding its product portfolio, or entering new international markets. This capital infusion is expected to fuel further innovation and solidify its competitive advantage in the global cannabinoid sector. The company's focus on international production and distribution suggests a strategy geared towards capturing market share across diverse geographical regions.
See full Cronos Group company page
